Evidence map›Paper›PMID 38757104›Full record

ArticleNorthern clinics of Istanbul2024

The effect of

Busra Ertas, Dogancan Dorucu, Oznur Gulerturk, Ali Sen, Ozge Cevik, Sule Cetinel, Pinar Eker, Asuman Akgun, Emre Tarik Sener, Goksel Sener

Abstract read
In one paragraph

Article in Northern clinics of Istanbul, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Busra ErtasDepartment of Pharmacology, Marmara University Faculty of Pharmacy, Istanbul, Turkiye.
Dogancan DorucuDepartment of Urology, Marmara University Faculty of Medicine, Istanbul, Turkiye.
Oznur GulerturkDepartment of Pharmacology, Marmara University Faculty of Pharmacy, Istanbul, Turkiye.
Ali SenDepartment of Pharmacognosy, Marmara University Faculty of Pharmacy, Istanbul, Turkiye.
Ozge CevikDepartment of Biochemistry, Adnan Menderes University Faculty of Medicine, Aydin, Turkiye.
Sule CetinelDepartment of Histology and Embryology, Marmara University Faculty of Medicine, Istanbul, Turkiye.
Pinar EkerDepartment of Biochemistry, Umraniye Training and Research Hospital, Istanbul, Turkiye.
Asuman AkgunDepartment of Pharmacology, Marmara University Faculty of Dentistry, Istanbul, Turkiye.
Emre Tarik SenerDepartment of Urology, Marmara University Faculty of Medicine, Istanbul, Turkiye.
Goksel SenerDepartment of Pharmacology, Fenerbahce University Faculty of Pharmacy, Istanbul, Turkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNephrolithiasis is a common urological disease that can lead to renal failure. Oxidative stress has been shown to be a contributing factor for nephrolithiasis and many agents have been studied to prevent and treat oxidative stress-related nephrolithiasis and renal damage.

methodsWistar albino rats were divided into four groups (n=8); control (C), ethylene glycol (EG), EG+preventive MC, and EG+curative MC groups. The nephrolithiasis model was created by adding 0.75% EG to drinking water for 8 weeks. Ultimately, 24-hour urine was collected to measure calcium, citrate, and creatinine levels. After decapitation, kidney tissues were harvested for histological analyses, measurement of osteopontin and 8-hydroxydeoxyguanosine (8-OHdG) levels, and N-acetyl-β-glucosaminidase (NAG), myeloperoxidase (MPO) and caspase-3 activities.

resultsIn 24-hour urine samples, calcium, citrate and creatinine levels were decreased in the EG group, while oxalate levels were increased and in treatment groups these parameters returned to control levels. MPO, 8-OHdG, caspase-3 and NAG activity were significantly increased in tissue and these changes were reversed in both MC groups. Histological findings also supported the biochemical parameters.

conclusionMC can reduce oxidative stress and histopathological changes in kidney tissues in rat nephrolithiasis model when used as either a preventive or therapeutic agent. If supported with further clinical trials, MC might have clinical implications in preventing oxidative renal cell injury and ultimately kidney stone formation.

Indexed as

Ethylene glycolhyperoxalurianephrolithiasisoxidative stressrenal insufficiency

Identifiers

PMID38757104
PMCPMC11095334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.